Literature DB >> 16968806

Premature mortality in patients with Addison's disease: a population-based study.

Ragnhildur Bergthorsdottir1, Maria Leonsson-Zachrisson, Anders Odén, Gudmundur Johannsson.   

Abstract

BACKGROUND: The survival rate of patients with primary adrenal insufficiency (Addison's disease) undergoing currently accepted replacement therapy is not known, although well-informed patients are considered to have a normal survival rate. In this study, we evaluated the mortality of patients with Addison's disease in Sweden.
METHODS: A population-based, retrospective, observational study was performed, using the National Swedish Hospital and Cause of Death Registers, covering the period from 1987-2001. After a diagnosis of Addison's disease, each patient was followed until the end of follow-up or death. Mortality was compared with that of the Swedish background population.
FINDINGS: We identified 1675 patients (995 women and 680 men) diagnosed with primary adrenal insufficiency. The average follow-up from initial diagnosis was 6.5 yr. Five hundred seven patients died during the study period compared with an expected 199. The risk ratio for all-cause mortality was 2.19 (confidence interval 1.91-2.51) for men and 2.86 (confidence interval 2.54-3.20) for women. The excess mortality in both men and women was attributed to cardiovascular, malignant, and infectious diseases. Concomitant diabetes mellitus was observed in 12% of the patients, but only contributed to the increased mortality to a minor extent.
INTERPRETATION: Compared with the background population, we observed that the risk ratio for death was more than 2-fold higher in patients with Addison's disease. Cardiovascular, malignant, and infectious diseases were responsible for the higher mortality rate.

Entities:  

Mesh:

Year:  2006        PMID: 16968806     DOI: 10.1210/jc.2006-0076

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  113 in total

Review 1.  Adrenal insufficiency: etiology, diagnosis and treatment.

Authors:  Nicola Neary; Lynnette Nieman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

2.  Co-morbidities, management and clinical outcome of auto-immune Addison's disease.

Authors:  Lalantha Leelarathna; Louise Breen; James K Powrie; Stephen M Thomas; Rustom Guzder; Barbara McGowan; Paul V Carroll
Journal:  Endocrine       Date:  2010-07-03       Impact factor: 3.633

3.  Acquired long QT interval in a recurrent septic female patient with polymorphic ventricular tachycardia due to primary acute adrenal insufficiency.

Authors:  Roja Soutodeh; Jürgen Götz; Ulrich Tebbe; Alessandro Cuneo
Journal:  Clin Res Cardiol       Date:  2010-12-14       Impact factor: 5.460

Review 4.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

5.  Pituitary gland: predictors of acromegaly-associated mortality.

Authors:  Anat Ben-Shlomo
Journal:  Nat Rev Endocrinol       Date:  2010-02       Impact factor: 43.330

6.  Patients treated with immunosuppressive steroids are less aware of sick day rules Than those on endocrine replacement therapy and may be at greater risk of adrenal crisis.

Authors:  M R Salehmohamed; M Griffin; T Branigan; M Cuesta; C J Thompson
Journal:  Ir J Med Sci       Date:  2017-05-04       Impact factor: 1.568

Review 7.  Adrenal insufficiency.

Authors:  Stefanie Hahner; Richard J Ross; Wiebke Arlt; Irina Bancos; Stephanie Burger-Stritt; David J Torpy; Eystein S Husebye; Marcus Quinkler
Journal:  Nat Rev Dis Primers       Date:  2021-03-11       Impact factor: 52.329

8.  Physiological Glucocorticoid Replacement in Adrenal Insufficiency: Does It Fix the Broken Clock?

Authors:  Matthew R Brown; Aleksey V Matveyenko
Journal:  J Clin Endocrinol Metab       Date:  2018-09-01       Impact factor: 5.958

9.  Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.

Authors:  Roberta Giordano; Federica Guaraldi; Elisa Marinazzo; Federica Fumarola; Alessia Rampino; Rita Berardelli; Ioannis Karamouzis; Manuela Lucchiari; Tilde Manetta; Giulio Mengozzi; Emanuela Arvat; Ezio Ghigo
Journal:  Endocrine       Date:  2015-07-17       Impact factor: 3.633

Review 10.  [Addison's disease].

Authors:  M Quinkler
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-08-22       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.